Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2026 · 10-Q
Revenue$249.53M$249.53M−6.6% vs Q1 2025 Net Income$47.47M$47.47M−3.3% vs Q1 2025 EPS Diluted$0.95$0.95−3.1% vs Q1 2025 Gross Profit$140,331,000−3.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$79,013,000+44.2% Free Cash Flowderived$78,175,000+45.8% Margins · derivedGross margin56.2%+1.6 pt vs Q1 2025
Operating margin28.8%+1.8 pt vs Q1 2025
Net margin19.0%+0.7 pt vs Q1 2025
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end